On the effect of biochemotherapy in metastatic malignant melanoma

Although immunotherapy and biochemotherapy have shown promise, producing a subset of durable responses, for the majority of patients with metastatic ...

On the effect of biochemotherapy in metastatic malignant melanoma ...

On the effect of biochemotherapy in metastatic malignant melanoma: An immunopathological evaluation. Håkansson Annika; Håkansson, Leif; Gustafsson, Bertil ...

Biochemotherapy for the treatment of metastatic malignant melanoma

Because of the inconsistent results of the available studies with regard to benefit (response, time to progression, and survival) and consistently high toxicity ...

Biochemotherapy of metastatic malignant melanoma. Predictive ...

The therapeutic efficacy of biochemotherapy in metastatic malignant melanoma still carries a low remission rate, but with some durable ...

Biochemotherapy for the treatment of metastatic malignant melanoma

The results of available studies are inconsistent with regard to benefit (response, time-to-progression, and survival) and show consistently high toxicity ...

Biochemotherapy of metastatic melanoma in patients with or without ...

The authors performed a retrospective analysis to determine whether the treatment of metastatic melanoma with biochemotherapy would result in ...

A meta-analysis of the randomised trials - ASCO Publications

Background: Metastatic melanoma is associated with a poor survival rate. High response rates have been reported for both chemotherapy and biochemotherapy.

Metastatic Melanoma: Chemotherapy to Biochemotherapy

patients with metastatic malignant melanoma. J Clin Oncol. 1991;9:1403. 30. Kirkwood JM,Strawderman MH,Ernstoff MS,et al. Interferon alpha-2b adjuvant ...

Biochemotherapy of melanoma - ScienceDirect.com

Although these phase II results appear superior to previous results with chemotherapy or immunotherapy alone, the true benefits of biochemotherapy can only be ...

Full article: Systemic Therapy for Unresectable Metastatic Melanoma

Five-year overall survival rates of patients treated with biochemotherapy and chemotherapy ± IFN were 17% and 7% (p = 0.0004), respectively. Ten-year overall ...

Biochemotherapy of metastatic melanoma in patients with or without ...

2007. American Cancer Society. KEYWORDS: malignant melanoma, brain metastases, stereotactic radiosurgery, biochemotherapy. The overall survival ...

Complex Combination Biochemotherapy Regimen in Advanced ...

There is currently no chemotherapy or chemoimmunotherapy regimen that has shown impact on survival in patients with metastatic melanoma. Different ...

On the effect of biochemotherapy in metastatic malignant melanoma

Bertil Gustafsson; Lennart Krysander; Björn Rettrup; Dirk Ruiter; Monique R Bernsen. List of references. Legha, Semin Oncol, № 24, с. S39; Khayat, J ...

Biochemotherapy in the treatment of metastatic melanoma in ...

Observed RRs were 18% complete response (CR), 27% partial response (PR), 9% stable disease (SD) and 46% disease progression. The median PFS was ...

Biochemotherapy with thymosin α1, interleukin-2 and dacarbazine ...

DTIC and interleukin-2 (IL-2), as single agents, have a limited anti-tumor activity in patients with metastatic melanoma. Experimentally, thymosin αl (TA1) ...

Metastatic Melanoma: Chemotherapy to Biochemotherapy

Biochemotherapy remains a promising new treatment for metastatic melanoma. A large Intergroup trial E3695 comparing concurrent biochemotherapy to combination ...

Biochemotherapy for the Treatment of Metastatic Malignant Melanoma

To estimate the overall effect of biochemotherapy on response, time-to-progression, and overall survival, data were abstracted from the published reports of ...

Biochemotherapy of metastatic malignant melanoma. On down ...

Immunotherapy and combination treatments such as biochemotherapy have shown promise, with higher response rates and a subset of durable responses; however, ...

Biochemotherapy for the treatment of metastatic malignant melanoma

Semantic Scholar extracted view of "Biochemotherapy for the treatment of metastatic malignant melanoma: a systematic review." by C. Hamm et al.

A meta-analysis of biochemotherapy (BCT) for the treatment of ...

A meta-analysis of biochemotherapy (BCT) for the treatment of metastatic malignant melanoma (MM) ... impact on survival in patients with metastatic MM. Due ...